Palvella Therapeutics Inc's Customers Performance

Name: Palvella Therapeutics Inc Customers by Division and Industry - CSIMarket
Creator: CSIMarket.com
License: https://csimarket.com/help/terms-of-use

PVLA

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.


PVLA's Source of Revenues		• List of PVLA Customers

for the same period Palvella Therapeutics Inc

• List of PVLA Customers

Palvella Therapeutics Inc's Business Units

Select the Relationship:

Customers ▼

Select the Category:

Comparison ▼

Customers ▼

Basic Report▼

Palvella Therapeutics Inc's Comment on Sales, Marketing and Customers

News about Palvella Therapeutics Inc Contracts

Expansion of Phase 3 SELVA Trial for QTORIN Rapamycin 3.9% Anhydrous Gel in Treating Microcystic Lymphatic Malformati...

In an exciting development for pediatric dermatology, Palvella Therapeutics has announced that its investigational therapy, QTORIN Rapamycin 3.9% anhydrous gel, is making strides toward addressing microcystic lymphatic malformations (MLMs). This novel topical treatment was recently featured in an oral presentation by Dr. Amy Paller, M.S. M.D. Chair of Dermatology at Northwestern University’s Feinberg School of Medicine, at the prestigious 15th World Congress of Pediatric Dermatology. The significance of the presentation was amplified by the recent expansion of the ongoing Phase 3 SELVA (Safety and Efficacy of Lymphatic Malformations Treatment Study) trial, now inclusive of pediatric patients aged 3 to 5 ye...

PVLA's Stock Performance relative to it's Customers

PVLA's vs. Customers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)

COMPANY NAME	MARKET CAP	REVENUES	INCOME	EMPLOYEES
Palvella Therapeutics Inc	2,144.24	-0.20	-49.30	29
SUBTOTAL	0.00	0.00	0.00	-

Sources: Palvella Therapeutics Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Palvella Therapeutics Inc’s corporate clients.
For your research, we’ve provided 9 tables on Palvella Therapeutics Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.